Centogene extends partnership with Takeda
CAMBRIDGE, Mass.— Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, has extended its partnership with Takeda Pharmaceutical Co. to diagnose patients with certain genetic disorders. As part of the agreement, which has been extended until March 2022, Centogene
